Faculty Recruitment in Novel Therapeutic Strategies for Neurodegenerative Disease

描述（由申请人提供）：本提案旨在通过生物医学研究核心中心（p30）机制，为埃默里大学在神经退行性疾病新治疗策略领域的研究能力寻求新的教师招聘支持。作为中心主任，Raymond Dingledine博士（药理学主席兼教授，医学院研究执行副院长）将与dr。Allan Levey（神经病学主席兼教授，神经退行性疾病中心主任）和Lian Li（副主席兼药理学教授）招募并指导一名高度积极的终身教职助理教授，从事神经退行性疾病的基础和/或转化研究，与开发对抗神经退行性疾病的新治疗策略相关。新招募的研究者将在药理学部门进行初级任命，在神经病学部门和神经退行性疾病中心进行二级任命。核心中心将利用对空间、人员和其他资源的慷慨机构支持，提供一个杰出的、协作的、跨学科的环境，以及一个全面、彻底和严格的教师发展和评估计划，以促进新教师的独立研究事业和专业发展。实现本申请中提出的目标将增加和扩大埃默里大学的多学科研究人员社区，重点关注神经退行性疾病的基础、转化和临床研究，建立和加强各组成部分之间的机构内关系，包括药理学和神经病学部门、神经退行性疾病中心、综合神经科学研究所、化学生物学发现中心和药物发现研究所。促进治疗神经退行性疾病的新治疗方法的发展。

DESCRIPTION (provided by applicant): This proposal seeks support for new faculty recruitment to chance research capacity at Emory University in the area of novel therapeutic strategies for neurodegenerative disease through the biomedical research core center (p30) mechanism. As the center director, Dr. Raymond Dingledine (Chairman and Professor of Pharmacology and the Executive Associate Dean for Research in the School of Medicine) will work with Drs. Allan Levey (Chairman and Professor of Neurology and Director of Center for Neurodegenerative Disease) and Lian Li (Vice Chair and Professor of Pharmacology) to recruit and mentor a highly motivated tenure- track Assistant Professor to conduct research focusing on the basic and/or translational studies of neurodegenerative disease, with relevance to the development of novel therapeutic strategies for combating neurodegeneration. The newly-recruited investigator will have primary appointment in the Department of Pharmacology and secondary appointments in the Department of Neurology and the Center for Neurodegenerative Disease. The core center will leverage generous institutional support for space, personnel, and other resources and provide an outstanding, collaborative, and interdisciplinary environment and a comprehensive, thorough, and rigorous faculty development and evaluation plan that foster independent research career and professional development of the new faculty member. Achieving the goals proposed in this application will augment and expand Emory's community of multidisciplinary researchers focusing on the basic, translational, and clinic studies of neurodegenerative diseases, establish and strengthen the intra-institutional relationships among various components, including Departments of Pharmacology and Neurology, Center for Neurodegenerative Disease, Comprehensive Neuroscience Institute, Chemical Biology Discovery Center, and Drug Discovery Institute, and facilitate the development of novel therapeutic approaches for treating neurodegenerative diseases.